BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 9421348)

  • 41. Optimizing antidepressant treatment: efficacy and tolerability.
    Deakin B; Dursun S
    Int Clin Psychopharmacol; 2002 Jun; 17 Suppl 1():S13-24. PubMed ID: 12369607
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Japanese experience with dual-action antidepressants.
    Tajima O
    Int Clin Psychopharmacol; 2002 Jun; 17 Suppl 1():S37-42. PubMed ID: 12369609
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Therapeutic potentials of recently introduced antidepressants. Danish University Antidepressant Group.
    Vestergaard P; Gram LF; Kragh-Sørensen P; Bech P; Reisby N; Bolwig TG
    Psychopharmacol Ser; 1993; 10():190-8. PubMed ID: 8361976
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Levomilnacipran extended-release: a review of its use in adult patients with major depressive disorder.
    Scott LJ
    CNS Drugs; 2014 Nov; 28(11):1071-82. PubMed ID: 25270036
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment strategies in achieving remission in major depressive disorder.
    Kelsey JE
    Acta Psychiatr Scand Suppl; 2002; (415):18-23. PubMed ID: 12492769
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sex Differences in Responses to Antidepressant Augmentations in Treatment-Resistant Depression.
    Moderie C; Nuñez N; Fielding A; Comai S; Gobbi G
    Int J Neuropsychopharmacol; 2022 Jun; 25(6):479-488. PubMed ID: 35167671
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A review of studies of the Montgomery-Asberg Depression Rating Scale in controls: implications for the definition of remission in treatment studies of depression.
    Zimmerman M; Chelminski I; Posternak M
    Int Clin Psychopharmacol; 2004 Jan; 19(1):1-7. PubMed ID: 15101563
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacotherapy for chronic depression.
    Friedman RA; Kocsis JH
    Psychiatr Clin North Am; 1996 Mar; 19(1):121-32. PubMed ID: 8677215
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical relevance of findings in trials of CBT for depression.
    Lepping P; Whittington R; Sambhi RS; Lane S; Poole R; Leucht S; Cuijpers P; McCabe R; Waheed W
    Eur Psychiatry; 2017 Sep; 45():207-211. PubMed ID: 28957788
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Is severe depression a separate indication? ECNP Consensus Meeting September 20, 1996, Amsterdam. European College of Neuropsychopharmacology.
    Montgomery SA; Lecrubier Y
    Eur Neuropsychopharmacol; 1999 Mar; 9(3):259-64. PubMed ID: 10208298
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Risks for oral health with the use of antidepressants.
    Peeters FP; deVries MW; Vissink A
    Gen Hosp Psychiatry; 1998 May; 20(3):150-4. PubMed ID: 9650032
    [TBL] [Abstract][Full Text] [Related]  

  • 52. How to improve the risk-benefit ratio of antidepressants.
    Corruble E; Puech AJ
    Int Clin Psychopharmacol; 1993; 8(4):237-41. PubMed ID: 8277141
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical application of time-dependent sensitization to antidepressant therapy.
    Antelman SM; Gershon S
    Prog Neuropsychopharmacol Biol Psychiatry; 1998 Jan; 22(1):65-78. PubMed ID: 9533167
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term drug treatment of unipolar depression.
    Hirschfeld RM
    Int Clin Psychopharmacol; 1996 Dec; 11(4):211-7. PubMed ID: 9031986
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Seligiline transdermal system in depression.
    Goodnick PJ
    Expert Opin Pharmacother; 2007 Jan; 8(1):59-64. PubMed ID: 17163807
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Milnacipran hydrochloride.
    Aust Prescr; 2017 Dec; 40(6):244-245. PubMed ID: 29375190
    [No Abstract]   [Full Text] [Related]  

  • 57. Long-term efficacy and safety of milnacipran compared to clomipramine in patients with major depression.
    Leinonen E; Lepola U; Koponen H; Mehtonen OP; Rimon R
    Acta Psychiatr Scand; 1997 Dec; 96(6):497-504. PubMed ID: 9421348
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative studies with milnacipran and tricyclic antidepressants in the treatment of patients with major depression: a summary of clinical trial results.
    Kasper S; Pletan Y; Solles A; Tournoux A
    Int Clin Psychopharmacol; 1996 Sep; 11 Suppl 4():35-9. PubMed ID: 8923125
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Milnacipran. A review of its use in depression.
    Spencer CM; Wilde MI
    Drugs; 1998 Sep; 56(3):405-27. PubMed ID: 9777315
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.